IndiaOne Finance - Company Dashboard

Governance Classic Home

Bharat Parenterals LtdPharmaceuticalsINE365Y01019Standalone₹1504.15-42.80 (-2.77%)Jun-26

Valuation

Market Cap₹1.04K Cr

TTM PE107.45x

Forward PE112.22x

PEG1.77

Book Value₹479.79

P/B3.15x

TTM EPS₹14.05

Fwd EPS₹13.45

TTM Revenue₹195.15 Cr

TTM PAT₹9.69 Cr

TTM EBITDA₹12.68 Cr

TTM EBIT₹4.11 Cr

Last Qtr PAT₹3.66 Cr

Last Qtr EBITDA₹6.83 Cr

Last Qtr EBIT₹4.57 Cr

Profitability

ROE2.93%

ROCE3.00%

TTM NPM4.97%

TTM EBITDA %6.50%

Curr OPM6.59%

Last OPM2.44%

Curr NPM—

Last NPM—

Curr EPS₹5.31

Last EPS₹2.00

Balance sheet

Equity₹6.89 Cr

Reserve₹323.78 Cr

Total Debt₹180.20 Cr

D/E0.54x

Interest %18.85%

Curr Interest₹0.69 Cr

Price / range

Close₹1509.70

vs 52W High-8.45%

vs 52W Low+71.51%

MA50—

MA200—

Returns

1D-1.58%

1W-0.80%

1M+16.85%

3M+14.71%

6M+48.78%

1Y+14.38%

2Y-9.18%

3Y+169.25%

5Y+647.38%

Diwali+24.77%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	148.17	3.58%
DIVISLAB	9375.00	₹2.49L Cr	84.62	17.55%
TORNTPHARM	4840.00	₹1.84L Cr	78.80	25.43%
ZYDUSLIFE	1160.00	₹1.16L Cr	33.21	12.96%
CIPLA	1394.50	₹1.13L Cr	36.64	8.93%
LAURUSLABS	1954.00	₹1.06L Cr	120.92	16.46%
AUROPHARMA	1734.00	₹99.77K Cr	38.79	6.84%
DRREDDY	1185.00	₹98.91K Cr	148.68	1.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	55.50-41.2%	56.54	41.41	41.70	94.37	234.02
Other Income	1.05	4.44	2.28	4.21	1.62	12.55
Total Income	56.55-41.1%	60.98	43.69	45.91	95.99	246.57
Interest	0.69	0.52	0.55	0.96	1.42	3.44
Expenditure	-51.62+37.4%	-59.06	-40.59	-42.49	-82.50	-224.73
PBDT	0	0	0	0	0	0
EBITDA	6.83-55.5%	0.04	3.47	2.34	15.35	21.10
Depreciation	-2.26	-2.04	-2.10	-2.17	-2.06	-8.37
EBIT	4.57-65.6%	-2	1.37	0.17	13.29	12.73
PBT	4.93-63.2%	1.93	3.10	3.42	13.40	21.84
Tax	-1.27	-0.55	-1.18	-0.69	-3.40	-5.82
Equity	0	0	0	0	0	0
OPM	8.88	3.41	7.48	8.20	14.20	9.00
Net Profit	3.66-63.4%	1.38	1.92	2.73	10	16.02
NPM	6.59	2.44	4.63	6.55	10.60	6.00
EPS	5.31	2	2.78	3.96	0	23.24

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	234.02-23.1%	304.13+19.7%	254.16+16.6%	217.98+2.8%	212.01+4.1%	203.67
Other Income	12.55	14.56	11.96	18.84	7.78	8.67
Total Income	246.57-22.6%	318.69+19.8%	266.12+12.4%	236.82+7.7%	219.79+3.5%	212.34
Expenditure	-224.73+20.4%	-282.37-20.0%	-235.32-15.0%	-204.65-6.9%	-191.42-3.3%	-185.32
Interest	-3.44	-4.79	-3.19	-2.19	-0.89	-0.76
PBDT	0	0	0	0	0	0
EBITDA	21.10-37.2%	33.60+18.2%	28.43+33.0%	21.37-24.1%	28.14+11.9%	25.14
Depreciation	-8.37	-7.05	-6.40	-5.85	-6.66	-6.03
EBIT	12.73-52.1%	26.55+20.5%	22.03+41.9%	15.52-27.7%	21.48+12.4%	19.11
PBT	21.84-39.9%	36.32+17.9%	30.80-4.3%	32.17+13.4%	28.37+5.0%	27.02
Tax	-5.82	-9.36	-8.24	-7.83	-7.07	-6.81
Equity	0	6.89	0	0	0	0
OPM (%)	9.00	11.40	12.00	14.00	13.00	13.00
Net Profit	16.02-39.4%	26.45+17.1%	22.59-7.2%	24.34+14.3%	21.30+5.4%	20.21
NPM (%)	6.00	8.30	8.00	10.00	10.00	10.00
EPS (Rs)	23.24-42.4%	40.36+4.0%	38.81-8.5%	42.40+14.3%	37.11+5.2%	35.27
CEPS	23.24	40.36	38.81	42.40	37.11	35.27

Metric	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	FY24-25
Revenue	65.19-9.8%	64.62	116	103.98	72.26	340.38
Other Income	1.33	3.53	1.06	2.20	2.95	11.90
Total Income	66.52-11.6%	68.15	117.06	106.18	75.21	352.28
Interest	0	3.11	3.69	4.22	3.33	13.23
Expenditure	-74.80+7.3%	-75.47	-114.50	-114.40	-80.71	-386.23
PBDT	0	0	0	0	0	0
EBITDA	-9.61-364.0%	0.82	13.79	2.32	3.64	2.70
Depreciation	0	-8.56	-8.60	-8.52	-8.76	-35.32
EBIT	-9.61-87.7%	-7.74	5.19	-6.20	-5.12	-32.62
PBT	0+100.0%	0	2.54	0	-5.50	-33.95
Tax	-1.39	-1.29	-3.40	-0.90	-2.37	-9.22
Equity	0	0	0	0	0	6.89
OPM	0.00	0.00	2.17	0.00	-7.31	-9.64
Net Profit	-9.67-22.9%	-8.61	-0.87	-9.44	-7.87	-43.68
NPM	-14.54	-12.63	-0.74	-8.89	-10.46	-12.40
EPS	0+100.0%	-14	-1.27	-14.40	-10	0

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21	FY 19-20
Revenue	340.38+32.3%	257.36+18.1%	217.98+2.8%	212.01+3.6%	204.64-10.3%	228.18
Other Income	11.90	8.59	11.74	7.78	8.67	11.48
Total Income	352.28+32.5%	265.95+15.8%	229.72+4.5%	219.79+3.0%	213.31-11.0%	239.66
Expenditure	-386.23-56.2%	-247.23-19.9%	-206.17-7.4%	-191.91-3.1%	-186.19+10.0%	-206.85
Interest	-13.23	-3.22	-2.19	-0.89	-0.77	-0.86
PBDT	0	0	0	0	0	0
EBITDA	2.70-87.9%	22.37+12.5%	19.88-28.1%	27.65+9.5%	25.25-10.0%	28.07
Depreciation	-35.32	-9.02	-5.88	-6.66	-6.03	-5.88
EBIT	-32.62-344.3%	13.35-4.6%	14-33.3%	20.99+9.2%	19.22-13.4%	22.19
PBT	-33.95-281.4%	18.72-20.5%	23.55-15.5%	27.88+2.8%	27.12-17.3%	32.81
Tax	-9.22	-8.23	-7.83	-7.07	-6.81	-8.65
Equity	6.89	0	0	0	0	0
OPM (%)	-9.64	7.04	10.25	12.68	12.71	13.69
Net Profit	-43.68-515.2%	10.52-33.1%	15.72-24.5%	20.81+2.5%	20.31-15.9%	24.16
NPM (%)	-12.40	3.96	6.84	9.47	9.52	10.08
EPS (Rs)	0-100.0%	8.65-69.5%	28.40-22.6%	36.67+3.0%	35.59-15.5%	42.14
CEPS	0	8.65	28.40	36.67	35.59	42.14

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2025	Final Dividend	1	19 Sep 2025
2024	Final Dividend	1	25 Jun 2024
2023	Final Dividend	0.75	25 Sep 2023

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split